HomeNLSP • NASDAQ
add
NLS Pharmaceutics AG
Previous close
$0.14
Day range
$0.13 - $0.15
Year range
$0.11 - $1.53
Market cap
5.59M USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.77M | -13.10% |
Net income | -3.81M | 11.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.77M | 13.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.65M | 21.95% |
Total assets | 2.27M | 10.31% |
Total liabilities | 6.56M | 7.50% |
Total equity | -4.29M | — |
Shares outstanding | 32.43M | — |
Price to book | -1.10 | — |
Return on assets | -415.69% | — |
Return on capital | 220.14% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -3.81M | 11.90% |
Cash from operations | -3.65M | 4.81% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -3.65M | -78.98% |
Free cash flow | -2.33M | 14.32% |
About
Founded
2015
Website
Employees
2